Corrigendum to “In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes-accelerated atherosclerosis” [J. Drug Deliv. Sci. Technol. 96 (2024) 105686] (Journal of Drug Delivery Science and Technology (2024) 96, (S1773224724003551), (10.1016/j.jddst.2024.105686))

Heba A. Abou-Taleb, Randa Mohammed Zaki, Ahmed A. Hefny, Obaid Afzal, Mary Girgis Shahataa, Fatma I. Abo El-Ela, Heba F. Salem, Amr Gamal Fouad

Research output: Contribution to journalComment/debate

Abstract

The authors regret < Acknowledgements: This study was supported via Prince Sattam Bin Abdulaziz University Project number (PSAU/2024/R/1445) >. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number106597
JournalJournal of Drug Delivery Science and Technology
Volume104
DOIs
StatePublished - Feb 2025

Fingerprint

Dive into the research topics of 'Corrigendum to “In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes-accelerated atherosclerosis” [J. Drug Deliv. Sci. Technol. 96 (2024) 105686] (Journal of Drug Delivery Science and Technology (2024) 96, (S1773224724003551), (10.1016/j.jddst.2024.105686))'. Together they form a unique fingerprint.

Cite this